Login
$NXTS
$0.55 -$0.03 (5.0%) After hours

Consolidated Interim Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
A s s e t s
Current Assets
Cash and cash equivalents
Restricted cash
Investment in marketable securities (Note 5 (2), 6)
Accounts receivable
Short term loan (Note 6 (1))
Inventories
Short term loan (Note 5(1))
Prepaid expenses
Other current assets
Assets of discontinued operations (Note 11A)
Assets held for sale
T o t a l Current assets
Long term prepaid expenses
Right-of-use asset arising from operating leases
Property and equipment, net
Investment in nonconsolidated affiliate (Note 10)
Long term loans (Note 4)
Long term loan (Note 6 (1))
Solar photovoltaic joint venture project (Note 5)
Solar projects under development (Note 9)
Solar projects under development
Investment in Solar Photovoltaic joint venture project (Note 5)
Investment in solar projects under development
Goodwill (Note 4)
Intangible asset (Note 3)
T o t a l assets
Liabilities and Shareholders’ Equity
Current Liabilities
Short term loan (Note 10 (2))
Accounts payable
Other liabilities
Current warrant liabilities (Note 8)
Liabilities of discontinued operations (Note 11A)
Current warrant liabilities
Current warrant liability
Liabilities held for sale
T o t a l current liabilities
Non-current operating lease liabilities
Credit facility (Note 9)
Stock purchase warrants liability (Note 15 (11))
Non-current warrant liability (Note 9)
Stock purchase warrants liabilities (Note 10(1))
Contingent considerations (Note 3)
Deferred taxes liability
T o t a l liabilities
Stockholders’ Equity
Common stock, $ 0.0001 par value (“Common Stock”): 495,000,000 shares authorized as of June 30, 2026 and December 31, 2025; issued and outstanding 1,453,333 and 396,386 shares as of June 30, 2026 and December 31, 2025, respectively.
Additional paid-in capital
Foreign currency translation adjustments
Accumulated deficit
T o t a l Company’s stockholders’ equity
Non-controlling interests
T o t a l stockholders’ equity
T o t a l liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support